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OBJECTIVE: Perivascular adipose tissue (PVAT) plays a vital role in maintaining vascular homeostasis. However, most studies 
ascribed the function of PVAT in vascular remodeling to adipokines secreted by the perivascular adipocytes. Whether 
mesenchymal stem cells exist in PVAT and play a role in vascular regeneration remain unknown.
APPROACH AND RESULTS: Single-cell RNA-sequencing allowed direct visualization of the heterogeneous PVAT-derived 
mesenchymal stem cells (PV-ADSCs) at a high resolution and revealed 2 distinct subpopulations, among which one featured 
signaling pathways crucial for smooth muscle differentiation. Pseudotime analysis of cultured PV-ADSCs unraveled their 
smooth muscle differentiation trajectory. Transplantation of cultured PV-ADSCs in mouse vein graft model suggested the 
contribution of PV-ADSCs to vascular remodeling through smooth muscle differentiation. Mechanistically, treatment with 
TGF-β1 (transforming growth factor β1) and transfection of microRNA (miR)-378a-3p mimics induced a similar metabolic 
reprogramming of PV-ADSCs, including upregulated mitochondrial potential and altered lipid levels, such as increased 
cholesterol and promoted smooth muscle differentiation.
CONCLUSIONS: Single-cell RNA-sequencing allows direct visualization of PV-ADSC heterogeneity at a single-cell level and 
uncovers 2 subpopulations with distinct signature genes and signaling pathways. The function of PVAT in vascular regeneration 
is partly attributed to PV-ADSCs and their differentiation towards smooth muscle lineage. Mechanistic study presents miR-
378a-3p which is a potent regulator of metabolic reprogramming as a potential therapeutic target for vascular regeneration.
VISUAL OVERVIEW: An online visual overview is available for this article.
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Perivascular adipose tissue (PVAT) anatomically abuts the adventitial side of the artery.1 Changes in the phenotype of PVAT correlates with disease progres-
sion, such as atherosclerosis, and the increase of volume 
and upregulation of inflammatory factors secreted by 
adipocytes are associated with worse outcomes.2 Loss 
of PVAT resulting from the specific deletion of PPAR-γ 
(peroxisome proliferator-activated receptor γ) in murine 
smooth muscle cells (SMCs) contributes to endothelial 
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dysfunction and impairs vascular homeostasis.3 More-
over, transplantation of PVAT to the adventitial side of 
femoral artery after de-endothelialization injury acceler-
ates neointimal hyperplasia.4 However, most studies have 
attributed the function of PVAT to cytokines such as 
MCP-1 (monocyte chemoattractant protein 1), and little 
is known about the possible impact of stem cells in the 
PVAT surrounding the vascular wall.3,4
Tissue-resident stem cells, including vascular progeni-
tors, are responsible for tissue remodeling.5,6 Adventitial 
stem/progenitor cells participate in vascular remodeling 
through migration towards the injury site and differen-
tiation towards vascular lineages including SMCs.7 Adi-
pose tissue-derived mesenchymal stem/stromal cells 
(ADSCs) from the subcutaneous and visceral fat display 
the potential to differentiate towards vascular lineages, 
including endothelial cells (ECs) and SMCs.8,9 Therefore, 
it remains to be explored whether PVAT-derived mesen-
chymal stem cells (PV-ADSCs) exist in the PVAT and 
contribute to vascular remodeling through vascular lin-
eage differentiation in vivo like adventitial stem/progeni-
tor cells.
Mesenchymal stem cells (MSCs) from different tis-
sues origins display similar phenotypic characteristics 
and multilineage differentiation potential in vitro, how-
ever, their well-documented heterogeneity has hindered 
major research progress in the field. Single-cell RNA-
sequencing (scRNA-seq) analysis allows transcriptome 
profiling at the single-cell level and might help to gain 
further insight about distinctive subpopulations.10 Recent 
studies have shown that metabolism which primarily 
sustains the energy need of stem cells regulates plu-
ripotency and differentiation.11 For example, fatty acid 
oxidation was found to be important for hematopoietic 
stem cell maintenance.12 To date, whether the induction 
of SMC differentiation by TGF-β1 (transforming growth 
factor β1) is, in part, due to the metabolic regulation has 
not been investigated.
In this study, we demonstrate the heterogeneity of 
PV-ADSCs at a single-cell level and uncover 2 distinct 
clusters with specific signature markers and signaling 
pathways. Next, we show that PV-ADSCs participate 
in vascular remodeling in vivo notably through SMC 
differentiation. In addition, we demonstrate that dur-
ing the SMC differentiation of PV-ADSCs, TGF-β1 and 
microRNA (miR)-378a-3p induce a metabolic repro-
gramming consisting of increased mitochondrial oxida-
tive metabolism, upregulated mitochondrial potential, and 
altered lipid levels, such as increased cholesterol level. 
Therefore, our study highlights the heterogeneity of PV-
ADSCs at the single-cell level, unravels their importance 
in vascular remodeling and presents miR-378a-3p as a 
potential therapeutic target to prevent pathological vas-
cular remodeling.
MATERIALS AND METHODS
The data that support the findings of this study are available 
from the corresponding author upon reasonable request. 
Detailed materials and methods are in the online-only Data 
Supplement.
Nonstandard Abbreviations and Acronyms
α-MEM  α-minimal essential medium
ACTA2  smooth muscle α actin
ADSCs   adipose tissue-derived mesenchy-
mal stem cells
CNN1  calponin
Crat  carnitine acetyltransferase
DAPI  4′,6-diamidino-2-phenylindole
ECs  endothelial cells
GO  gene ontology
IL  interleukin
MCP-1  monocyte chemoattractant protein 1
miR  microRNA
MSC  mesenchymal stem/stromal cells
OCR  oxygen consumption rate
PPAR-γ   peroxisome proliferator-activated 
receptor-γ
PV-ADSCs   perivascular adipose tissue-derived 
mesenchymal stem cells
PVAT  perivascular adipose tissue
RFP  red fluorescent protein
Sca-1  stem cell antigen 1
scRNA-seq  single-cell RNA-sequencing
SMCs  smooth muscle cells
TGF-β1  transforming growth factor β1
TMRM   tetramethylrhodamine, methyl ester, 
perchlorate
Highlights
• Single-cell RNA-sequencing allows direct visualiza-
tion of perivascular adipose tissue-derived mesen-
chymal stem cell heterogeneity at a single-cell level 
and uncovers 2 subpopulations with distinct signa-
ture genes and signaling pathways.
• The function of perivascular adipose tissue in vas-
cular regeneration is partly attributed to perivascular 
adipose tissue-derived mesenchymal stem cells and 
their differentiation towards smooth muscle lineage.
• TGF (transforming growth factor)-β1 and miR-
378a-3p mimics induced a similar metabolic repro-
gramming of perivascular adipose tissue-derived 
mesenchymal stem cells, including upregulated 
mitochondrial potential and altered lipid levels such 
as increased cholesterol and promoted smooth mus-
cle differentiation.
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Experimental Mice
All animal procedures were approved by the UK Home 
Office. C57BL/6J mice were purchased from The Jackson 
Laboratory. Male mice aged 8 to 10 weeks were selected for 
surgery. Only male mice were selected for minimization of data 
variation brought by difference of sex. Breeding pairs of miR-
378a-knockout mice (129SvEv/C57BL/6/mir-378-KO) were 
kindly provided by Dr Eric Olson (University Texas Southwestern 
Medical Centre, Dallas, TX) and crossed with C57Bl/10ScSn-
Dmdmdx/J mice for testing miR-378a effects in Duchenne 
muscular dystrophy (other work, in preparation). Protocols from 
the Institutional Committee for Use and Care of Laboratory 
Animal and license issued by Home Office, United Kingdom, 
were followed in all animal procedures.
Primary Culture of Adipose Tissue-derived 
Stem Cells from Mouse
Periaorta adipose tissues surrounding thoracic aorta (from the 
aortic arch to the aortic hiatus) of five 8-week-old C57BL/6J 
mice were pooled for each primary culture. Finely minced adi-
pose tissue was washed with PBS once and then digested with 
2 mg/mL collagenase type I (Life Tech, 17018–029) for 30 
minutes at 37°C in a shaker with a speed set at 100 rpm. The 
pellet was resuspended in stem cell culture medium (α- mini-
mal essential medium [MEM] with 15% embryomax [Millipore, 
ES-009-B], 0.1 mmol/L 2-mercaptoethanol [Sigma], 10 ng/
mL recombinant human leukemia inhibitory factor [Chemicon, 
Temecula, CA], 5 ng/mL bFGF [basic fibroblast growth fac-
tor; R&D systems], 2 mmol/L L-glutamine [Sigma], 100 U/mL 
penicillin, and 100 mg/mL streptomycin [GIBCO, Grand Island, 
NY]) and placed in a 5% Co2 incubator. ADSCs from miR-378a 
knockout mice were isolated from the inguinal subcutaneous 
adipose tissue and cultured in the same manner. Cells within 
10 passages were used.
Phenotyping of Primary and Cultured PV-ADSC
Primary cells obtained after the enzymatic digestion of peri-
aorta adipose tissue or cultured cells detached with scraptase 
(GenDEPOT) were stained for 30 minutes at 4°C with follow-
ing antibodies: anti-CD45-APC (BD Biosciences, 561018), 
anti-CD29-PE (BD Biosciences, 562801), anti-Sca-1 (stem 
cell antigen 1)-PE-Cy7 (Biolegend, 108113), anti-CD31-
PerCP (Biolegend, 201419), anti-CDH5-Alexa Fluor 647 (BD 
Biosciences, 562242), anti-PDGFRα-APC (platelet-derived 
growth factor α; eBioscience, 17-1401-81), anti-CD117-PE 
(Biolegend, 105807), anti-CD34-APC (Biolegend, 128611), 
anti-CD44-PerCP (Biolegend, 103035), and anti-CD11b-PE 
(Biolegend, 101205). Nucleated cells were distinguished from 
debris with Syto16 (Molecular Probes, S7578) and dead cells 
with 4′,6-diamidino-2-phenylindole (DAPI). Cells were ana-
lyzed with BD Accuri C6 or BD LSR Fortessa II (both Becton 
Dickinson). Gating was set with appropriate fluorescence minus 
one controls or corresponding IgG controls.
Sorting and scRNA-Seq of PV-ADSCs
Periaorta adipose tissue surrounding thoracic aorta (from the 
aortic arch to the aortic hiatus) was enzymatically digested 
to obtain primary PV-ADSCs. The cell suspensions were 
stained with Syto16, DAPI, CD45, CDH5, CD29, and Sca1 as 
described earlier in the phenotyping of primary and cultured 
PV-ADSCs. After proper gating, the single Syto16+/DAPI−/
CD45−/CDH5−/CD29+/Sca1+ population were taken for sub-
sequent scRNA-seq. RNA libraries were prepared on the con-
tactless liquid handling system Labcyte Echo 525 (Labcyte Inc). 
Data quality was assessed with FastQC, reads were aligned to 
mouse genome (mm9) with HiSat2 2.0.5, sorted with SamTools 
1.4 and assembled with StringTie 1.3.3.13 R package scater was 
used for quality control (85 out of 94 cells with aligned reads 
>800 000 were selected for further analysis) and normaliza-
tion (default scaling normalization).14 Automated Single-cell 
Analysis Pipeline with log-transformed and normalized values 
as input was used for multidimensional scaling, clustering, dif-
ferential expression (SCDE).15 Heatmaps and violoin plots of 
scRNA-seq data were plotted with R package ggplot2. Gene 
ontology and Kyoto encyclopedia of genes and genomes path-
way analysis were performed with DAVID website.16 Gene set 
enrichment analysis was performed with GSEA software.17
For scRNA-seq of cultured PV-ADSCs, enzymatically 
digested cells that attached to the flask surface after 3 days 
(in α-MEM with 10% FBS) and reached 80% confluency 
were dissociated and encapsulated in a gel bead and loaded 
to GemCode Instrument (10X Genomics) which generated 
barcoded single-cell droplets. Sequencing was performed with 
standard protocol using 10X Single Cell 3’ v2 and 10X chro-
mium system. The library was sequenced with Nova PE150. 
In total, 12 158 cells were sequenced in one run. R package 
Seurat (version 2.3.0)18 was leveraged for subsequent qual-
ity control and clustering analysis. Cells expressing <200 or 
>5000 genes were filtered out for exclusion of noncell or cell 
aggregates. Cells with a percentage of mitochondrial genes 
>0.05 were also filtered out. After quality control, 11 878 cells 
were included in subsequent analysis. After log-normalizing the 
data, principle component analysis was performed for dimen-
sion reduction. Clusters generated with the first 10 principal 
components were visualized with t-distributed stochastic near-
est neighbor embedding. Expression of selected genes was 
plotted with Seurat function FeaturePlot.
Adult subcutaneous adipose tissue stromal vascular cells 
in published data sets (GSM371797819 and E-MTAB-667720) 
were analyzed with corresponding methods described in the 
literature. Clustering-specific markers for each mesenchymal 
stem cell population were found with MSC population subseted 
Seurat (version 3) object.
Pseudotime Trajectory Analysis
Pseudotime trajectory was plotted with R package monocle 
version 2.4 with default settings. Pseudotime ordering was 
performed using function reduceDimension with max_compo-
nents set at 2 and reduction_method set as DDRTree. Cells 
that express Acta2 but do not express Myl6, Cnn1, or Myh11 
were set as starting point of pseudotime. Significant genes are 
obtained with function differentialGeneTest (fullModelFormu-
laStr =~Pseudotime) and plotted with function plot_pseudo-
time_heatmap (num_clusters =3). In the heatmap, predicted 
values generated by function genSmoothCurves were plotted 
along 100 evenly spaced pseudotime values.21 Genes included 
in Kyoto encyclopedia of genes and genomes term TGF-β sig-
naling or transcription factors (list obtained from transcription 
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factor database22) were intersected with the 3 significantly 
changed gene modules and presented as heatmap. Branch 
point analysis was performed with BEAM function.
Smooth Muscle Differentiation
PV-ADSCs were seeded on gelatin-coated flasks and differ-
entiated with medium (α-MEM with 10% FBS and 5 ng/mL 
TGF-β1 [R&D systems]) for indicated time. Leptin (Peprotech, 
450-31) or IGFBP-2 (R&D Systems, 797-B2-025) at indicated 
concentrations were used to manipulate differentiation.
RFP Labeling of Cells
Lentiviral particles used to label PV-ADSCs with RFP (red fluo-
rescent protein) were generated with LV H2b_RFP plasmid23 (a 
gift from Elaine Fuchs, Addgene, 26001).
Subcutaneous Matrigel Plug Assay
Subcutaneous Matrigel plug assay experiments were con-
ducted as described.6,24,25 PV-ADSCs were differentiated for 
5 days with αMEM with 10% FBS 5 ng/mL TGF-β1. Mouse 
MS1 ECs (ATCC, CRL-2279) were prepared. Differentiated 
PV-ADSCs and mouse ECs were mixed in a 1:1 ratio in 100 
μL Matrigel and injected subcutaneously to mice. The plugs 
were harvested 14 days after the injection for immunostaining 
and H&E staining. To track the PV-ADSCs, RFP-labeled cells 
were used.
Cell Transplantation
Mouse vein segments were isografted into carotid arteries of 
C57BL/6J mice.26 RFP-labeled PV-ADSCs in culture (106 
cells) were seeded onto the adventitial side to envelope the 
vein grafts. Vein graft transplantation without cell wrapping was 
used as control. Grafted tissue fragments were harvested 2 
weeks postsurgery and stained with H&E and immunofluores-
cent markers.
1H Nuclear Magnetic Resonance Metabolomics 
Analysis
Undifferentiated ADSCs and ADSCs cultured in differentiation 
medium (α-MEM with 10% FBS and 5 ng/mL TGF-β1) for 1 
day were harvested and frozen in liquid nitrogen. Eight samples 
were acquired in each treatment and 1H nuclear magnetic res-
onance metabolomics was performed using method published 
with modifications.27
Gas Chromatography-Mass Spectrometry 
Metabolomics Analysis
Undifferentiated ADSCs, ADSCs differentiated for 4 days, cells 
treated with miRNA mimic negative control or miR-378a-3p 
mimics were harvested, frozen in liquid nitrogen before analysis. 
Extraction of metabolites was done using a published protocol 
with modification.28
Metabolomics Data Processing
Annotated metabolites and correspondent abundance were 
normalized to the total level of metabolites. Data scaling was 
mean-centered and divided by SD of each variable. Orthogonal 
projection to latent structures analysis29 and heatmap of vari-
ous metabolites were obtained from MetaboAnalyst software.30
Transfection of MiRNA Mimics, MiRNA 
Inhibitors, and SiRNAs
PV-ADSCs with 70% confluence were transfected with 
miRNA mimics, inhibitors or siRNAs (Thermo Fisher) with 
Lipofectamine RNAiMAX (Thermo Fisher). After optimization, 
the concentrations of miRNA mimics, miRNA inhibitors, and 
siRNAs were respectively 12.5, 60, and 12.5 nmol/L.
Oxygen Consumption Rate and Extracellular 
Acidification Rate Measurements
Oxygen consumption rate (OCR) and extracellular acidification 
rate are measured with the Seahorse XF-24 extracellular flux 
analyzer (Seahorse Bioscience). PV-ADSCs with indicated treat-
ments and corresponding controls were plated on XF-24 micro-
plate coated with gelatin one day before the assay. XF Cell Mito 
Stress Kit was used to study the mitochondrial metabolism. OCR 
and extracellular acidification rate at basal level and after meta-
bolic perturbations with the addition of 1 μmol/L oligomycin, 1 
μmol/L carbonyl cyanide-p-trifluoromethoxyphenylhydrazone, and 
1 μmol/L rotenone and anti-mycin A were measured. Calculations 
were obtained with the Agilent Seahorse Wave Software for 
Agilent Seahorse XF analyzers (Seahorse Bioscience).
Statistical Analysis
Data with 5 or more experiment repeats passed KS normality 
test that determines data normality and the F test that assesses 
homogeneity of variance. Unpaired and 2-tailed Student t test 
were applied to analyze data between 2 groups. Data were 
expressed as mean±SD using GraphPad Prism 6. Comparisons 
across multiple groups with 5 experiment repeats per group 
were assessed with 1-way ANOVA test, followed by Bonferroni 
post hoc analysis. Comparisons across multiple groups with 
3 experiment repeats per group were assessed with the 
Kruskal-Wallis test, followed by Bonferroni post hoc analysis. 
Experiment repeats in each group were specified in the figure 
legends. P<0.05 was considered statistically different.
Data Availability
Clustering result of primary PV-ADSC scRNA-seq data has 
been made public on the Automated Single-cell Analysis 
Pipeline website (https://asap.epfl.ch) with the project 
name PV-ADSC scRNA-seq. Raw sequencing data of pri-
mary PV-ADSCs are available in Gene Expression Omnibus 
(GSE132581). Additional data are available from the corre-
sponding author on request.
RESULTS
Characterization and Localization of Stem Cells 
in the PVAT
MSCs exist in almost all organs of the body.31 ADSCs 
from the subcutaneous fat exhibit potential for tissue 
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remodeling with multilineage differentiation capacities 
and immunomodulation effect.32 Thus, we hypothesized 
that MSCs also reside in the PVAT. To examine this, the 
adipose tissue surrounding mouse thoracic aorta was 
enzymatically digested and cultured in vitro. In the isolated 
adipose tissue, similar coverage of PLIN-1 (perilipin-1), 
an adipocyte marker with cell nucleus as well as mini-
mal staining of PLIN-1 in remaining adventitia confirms 
minimal contamination of adventitial cells (Figure I in the 
online-only Data Supplement), although slight contami-
nation could not be excluded given the proximity of peri-
aorta adipose tissue and adventitia. More than 95% of 
the cells express MSC marker CD29 and 73.55±2.85% 
express mouse stem cell marker Sca1 (Figure 1A and 
1B). CD34, which is also an MSC marker,33 displayed 
high expression in around 68.30±2.70% of the cultured 
cells (Figure 1A and 1B). Furthermore, only 1% to 3% 
of the cells express hematopoietic marker CD45, mac-
rophage marker CD11b, progenitor marker c-Kit, and 
endothelial marker PECAM1 (platelet and endothelial 
cell adhesion molecule 1; Figure 1A and 1B). In addition, 
around 63% of the cells expressed pericyte or fibroblast 
marker PDGFRa and >95% expressed CD44 (Figure IIA 
in the online-only Data Supplement). Furthermore, the 
cells isolated from the PVAT exhibited adipogenic and 
osteogenic differentiation capacities (Figure IIB through 
IIE in the online-only Data Supplement). Thus, in consis-
tency with the in vitro definition of MSCs proposed by 
the International Society for Cellular Therapy,34 pheno-
typic analysis, and multilineage differentiation capacities 
confirmed the existence of MSCs within the periaorta 
adipose tissue. These cells are referred to as PV-ADSCs 
below.
After characterization of the phenotypic markers, the 
in situ localization of PV-ADSCs was studied. To exclude 
ECs and adipocytes from the PV-ADSC population, 
staining of endothelial marker PECAM1 and adipocytes 
marker PLIN-1 was performed. MSC marker CD29 was 
used because of its consistent and high expression in 
primary periaorta adipose tissue cells (Figure 2A) and 
cultured PV-ADSCs (Figure 1). As adventitial Sca-
1+ cells play a crucial role in neointima formation and 
vascular pathogenesis,35 Sca-1 expression in CD29+/
PECAM1−/PLIN1− cells was examined. The results 
showed that PVAT contains a population of CD29+/
PLIN1−/PECAM1− cells and that some of the cells coex-
press Sca-1 (Figure 1C). To conclude, a CD29+/Sca1+/
PLIN1−/PECAM1− PV-ADSC population was identified 
in the PVAT.
ScRNA-Seq of PV-ADSCs Reveals 2 Distinct 
Clusters
Heterogeneity has been a long-standing question in the 
research field of MSCs.34 To achieve a high-resolution 
phenotyping of the PV-ADSCs, scRNA-seq was used. 
Among the enzymatically digested periaorta adipose 
tissue cells (freshly isolated cells without in vitro cul-
ture), single live cells were sorted for CD45−/CDH5− 
population to exclude the hematopoietic and endothelial 
lineages (Figure 2A). Subsequently, scRNA-seq was 
performed in CD29+/Sca1+ cells (60.15±3.17% in non-
immune nonendothelial cells; Figure 2A; Figure IIIA in 
the online-only Data Supplement). Selection of CD29 
and Sca1 as the positive markers of PV-ADSCs was 
supported by our previous phenotypic and in situ char-
acterization and previous publications.20,36 Interestingly, 
Dpp4+ interstitial progenitors in mouse subcutaneous 
inguinal white adipose tissue showed an enrichment of 
Sca-1 compared with committed Icam1+ proadipocytes 
(Figure IIIB in the online-only Data Supplement), which 
further supported the use of Sca-1 for enrichment of 
ADSCs.19
Among the 94 single cells captured, 85 cells with 
the number of aligned reads >800 000 were selected 
for further analysis (Figure IIIC in the online-only Data 
Supplement). Two distinct clusters (cluster 1 and clus-
ter 2) were identified which contained 30 and 55 cells, 
respectively (Figure 2B). Cluster 2 featured the expres-
sion of Tgfbr2, an important component of TGF-β 
signaling pathway (Figure 2C), whereas cluster 1 exclu-
sively expressed Pecam1 (Figure IIIH in the online-only 
Data Supplement), an endothelial marker and Cd36 
(Figure 2C and 2D), which is important for fatty acid 
uptake. The signature genes for clusters 1 and 2 were 
illustrated as a heatmap (Figure 2D). Important sig-
naling pathways in cluster 1 included VEGF (vascular 
endothelial growth factor)-activated receptor activ-
ity and PPAR signaling (Figure 2E). The feature sig-
naling pathways for cluster 2 were those essential in 
smooth muscle differentiation, such as PDGF binding, 
IGF (insulin-like growth factor) binding, PI3K (phos-
phatidylinositol 3-kinase)-Akt (AKT serine/threonine 
kinase 1) signaling, and TGF-β signaling (Figure 2F). 
Furthermore, gene sets of myogenesis and TGF-β 
signaling presented a positive correlation with cluster 
2 (Figure 2G). The results implied that cluster 1 cells 
display angiogenic potential, whereas cluster 2 cells 
demonstrate enriched expression of genes involving 
pathways that are important in SMC differentiation.
Single-cell level examination of MSC or pericyte 
markers including Mcam,31 Tbx1837, Cspg4,31 and Pdg-
fra,36 etc, revealed substantial heterogeneity at a high 
resolution (Figure 2H). High expression of Ly6a was 
observed in both clusters, while other markers, such as 
Cd34, Cd44, Pdgfra, and Pdgfrb, were mainly expressed 
in cluster 2 (Figure 2I). Heterogeneous expression of 
stemness markers, such as Klf4 and Myc,38 was also 
observed (Figure IIID in the online-only Data Supple-
ment). Additionally, the cells in cluster 1 demonstrated 
exclusive expression of adipogenesis markers Fabp4 
and Pparg (Figure IIIE and IIIF in the online-only Data 
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Supplement). Endothelial marker Cdh5 was also mainly 
expressed in cluster 1 cells (Figure IIIG and IIIH in the 
online-only Data Supplement). No cell expressed SMC 
markers, including Cnn1, Tagln, Acta2, and Myh11 
(not shown). Interestingly, fibroblast markers such as 
Vimentin demonstrated heterogeneous expression 
in primary PV-ADSCs (Figure IV in the online-only 
Data Supplement). Relatively limited heterogeneity 
resulted from the relatively small number of cells ana-
lyzed was complimented by analysis of published data 
sets which offered clue of subcutaneous stromal vas-
cular cell hierarchy (Figure V in the online-only Data 
Figure 1. Characterization of perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs).  
A and B, Representative histograms of flow cytometry analysis of cultured PV-ADSCs and the percentage of indicated phenotypic markers (n=3). 
Gating is set for the IgG control to be between 0.5% and 1%. C, Immunofluorescent staining of the adipose tissue surrounding the mouse aorta 
with CD29, Sca-1 (stem cell antigen 1), PECAM1 (platelet and endothelial cell adhesion molecule 1), PLIN-1 (perilipin-1), and 4′,6-diamidino-2-
phenylindole (DAPI; n=3). Arrows indicate the CD29+/Sca1+/PECAM1−/PLIN1− cells. The border between End (endothelium), Med (media), 
Adv (adventitia), and perivascular adipose tissue (PVAT) is drawn with dashed line. Scale bar, 50 μm. Ctrl indicates IgG isotype control.
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Supplement).19,20 To conclude, scRNA-seq allowed 
unprecedented direct visualization of MSC hetero-
geneity, revealing 2 distinct clusters with discrete 
signature gene sets and signaling pathways. Mul-
tiple gene sets involved in SMC differentiation were 
enriched in cluster 2.
Figure 2. Single-cell RNA-sequencing (scRNA-seq) reveals 2 distinct clusters in perivascular adipose tissue-derived 
mesenchymal stem cells (PV-ADSCs).  
A, Sorting gate for scRNA-seq was set as live nucleated cells (Syto16+/DAPI−), single cells, CD45−/CDH5− cells and CD29+/Sca1+ cells. B, 
Scatter plot obtained from multidimensional scaling (MDS) analysis showed 2 distinct clusters. Color scale, log2(gene counts). C, Expression 
of representative genes for cluster 1 (Cd36) and cluster 2 (Tgfbr2). D, Heatmap of marker genes in each cluster. Color scale, log2(gene 
counts). Full list of genes was in Table I in the online-only Data Supplement. E and F, Gene ontology (GO) and Kyoto encyclopedia of genes 
and genomes (KEGG) pathway analysis of the top 200 genes (by P value) upregulated in Cluster 1 (E) and Cluster 2 (F). Full list of GO 
terms and KEGG pathways was in Table II in the online-only Data Supplement. G, Enrichment of gene sets including Myogenesis (Molecular 
Signature) and TGF (transforming growth factor)-β signaling (KEGG). H, Expression heatmap of frequently used mesenchymal stem/stromal 
cell (MSC) markers. Color scale, log2(gene counts). I, Expression of frequently used MSC markers in the 2 clusters was shown as violin plot. 
Cl 1 indicates cluster 1; Cl 2, cluster 2; DAPI, 4′,6-diamidino-2-phenylindole; FDR, false discovery rate; GOMF, gene ontology molecular 
function; NES, normalized enrichment score; and PPAR-γ, peroxisome proliferator-activated receptor-γ.
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Pseudotime Analysis of Cultured PV-ADSCs 
Uncovers an SMC Differentiation Trajectory
While scRNA-seq of primary PV-ADSCs reflected their 
function and heterogeneity in vivo, further scRNA-seq 
of cultured PV-ADSCs offered an opportunity to exam-
ine a larger number of cells. In total, 12 158 cells were 
detected, with a median 2602 genes per cell. After qual-
ity control by including cells with gene number between 
200 and 5000 and filtering out cells with fraction of 
mitochondrial genes higher than 0.05, 11 878 cells were 
leveraged for subsequent analysis (Figure VIA and VIB 
in the online-only Data Supplement). Consistent with our 
previous flow cytometry data (Figure 1A), cultured PV-
ADSCs exhibited minimal level of Cdh5 expression with 
only 0.48% of the cells positive for Cdh5 (Figure VIC and 
VIE in the online-only Data Supplement). On the contrary, 
Tgfbr2 and Col3a1, both marker genes of cluster 2 in pri-
mary PV-ADSCs, displayed high expression in cultured 
PV-ADSCs with 29.26% and 93.79% of the cells positive 
for these markers, respectively (Figure VIC and VIE in the 
online-only Data Supplement). Interestingly, 6.23% of the 
cells expressed mature SMC marker Myh11 (Figure VID 
and VIE in the online-only Data Supplement). Additionally, 
most of the 15 cluster 1 marker genes displayed expres-
sion in <5% cultured cells, whereas most of the cluster 2 
marker genes were expressed in >25% of the cultured 
cells (Figure VIF in the online-only Data Supplement).
Pseudotime trajectory analysis was used to inspect 
progression of continuous cell states. It is noted here that 
the trajectory here was not complimented by real differ-
entiation time points and thus offers only suggestions of 
differentiation mechanism, which requires further experi-
mental proof. Because the PV-ADSCs were kept in basal 
conditions without additional stimulation factor towards 
adipocytes or osteocytes, minimal expression of markers 
for these cell types were expressed (Figure VIIA in the 
online-only Data Supplement). Cultured PV-ADSCs dis-
played different level of Acta2, Myl6, Cnn1, and Myh11 
expression (Figure 3A; Figure VIIB in the online-only 
Data Supplement). Pseudotime analysis ordered cells 
expressing different levels of SMC markers in a trajec-
tory (Figure 3B). Mature SMCs (stage 4) were located 
towards the termini of the trajectory, which is partly a 
validation for the constructed trajectory (Figure 3C). Sig-
nificantly changed genes along the pseudotime trajec-
tory were assigned to 3 gene modules (Figure 3D). In 
the downregulated gene module were Lpl (Figure 3D), an 
enzyme important for lipid metabolism,39 stem cell marker 
Ly6a (Figure 3E), and fibroblast marker Dcn (Figure VIIB 
in the online-only Data Supplement). Vim and Tpm3 were 
from gene module 2 and upregulated along the pseudo-
time, peaking in the middle of the trajectory (Figure 3D). 
SMC marker Acta2, pericyte marker Mcam, and MSC 
marker Cd44 were in gene module 3, reaching highest 
expression towards the end of trajectory (Figure 3D). For 
the upregulated genes (gene module 2 and 3), essential 
pathways for SMC differentiation such as HDAC (histone 
deacetylase) binding, histone binding, acting binding, IGF 
binding, and TGFR binding were enriched (Figure 3F). In 
the TGF-β signaling pathway, the upregulation of Tgfb1 
(in gene module 2), Rock2, and Rhoa (in gene module 3) 
along pseudotime trajectory further underlines the impor-
tance of this pathway in SMC differentiation (Figure 3G). 
In particular, Tgfb2 and also the total level of significantly 
changed genes in TGF-β signaling were increased during 
differentiation (Figure 3H). Importantly, along the trajec-
tory, Cebpb, which is crucial for adipogenesis, and Runx1, 
which drives osteocyte differentiation,40 decreased (Fig-
ure 3I). It is noted that pseudotime heatmap plots pre-
dicted values generated by function genSmoothCurve 
in monocle (version 2) along 100 evenly spaced pseu-
dotime values rather than real expression values.21 Cells 
located at the branches of the trajectory including states 
8, 7, 5, and 9 demonstrated enriched expression of genes 
involved in gene ontology terms antioxidant activity, lam-
inin binding, hormone receptor binding, and IL (inter-
leukin)-1 activity receptor binding respectively, which is 
consistent with the broad spectrum of function reported 
for mesenchymal stem cells such as immunomodulation 
(Figure VIII in the online-only Data Supplement).41
PV-ADSCs Participate in Vascular Remodeling 
In Vivo and Differentiate Towards SMCs In Vitro
Both adventitial progenitors and PV-ADSCs are located 
close to the aorta, among which adventitial progeni-
tors have been demonstrated to participate in vascular 
remodeling.7 To better characterize PV-ADSCs, com-
parison of their single-cell level transcriptomic signature 
with adventitial mesenchyme cells (Adventitial Mesen 
I-IV clusters)42 were performed. Cluster-defining genes 
for Adv-Mesen cells were enriched in cluster 2 cells of 
primary PV-ADSCs, with Mesen II cluster markers most 
highly expressed (Figure IXA in the online-only Data Sup-
plement). Additionally, only cluster 2 markers were highly 
expressed in Adv-Mesen cells and their slight enrichment 
in Mesen II cluster was also observed (Figure IXB in the 
online-only Data Supplement). Comparison of Sca1+ 
(normalized expression >1) cells from Adv-Mesen cells 
and cultured PV-ADSCs was further conducted. Interest-
ingly, Ccl2 (C-C motif chemokine ligand 2), which proved 
important for the proinflammatory function of adventitial 
Sca1+ cells,42 was among the genes with high variation 
in both groups (Figure IXC from online-only Data Sup-
plement). Various genes were differentially expressed in 
Sca1+ Adv-Mesen cells and cultured PV-ADSCs, among 
which fibroblast marker Dcn (decorin) and actin filament 
regulating Gsn (gresolin) were enriched in Adv-Mesen 
cells, and Timp1 (tissue inhibitor of metalloproteinases 
1) and S100a4 (S100 calcium binding protein A4) were 
highly expressed in cultured PV-ADSCs (Figure IXD 
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and IXE in the online-only Data Supplement). In terms 
of pathway analysis, genes expressed higher in cultured 
PV-ADSCs displayed enrichment of gene ontology terms 
actin binding and actin filament binding, whereas those 
selectively expressed in Adv-Mesen cells were enriched 
for gene ontology term chemokine activity and antioxidant 
Figure 3. Pseudotime trajectory of cultured perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs).  
A, Cell stages expressing early to late smooth muscle cell (SMC) markers. B, Pseudotime trajectory of cultured PV-ADSCs with DDRTree method for 
dimension reduction. Color scale, pseudotime. C, Cell ordering from different differentiation stages along the pseudotime trajectory. D, Heatmap of 
the top 1000 (by Q value) significantly changed genes in 3 gene modules. E, Expression of Ly6a, Cnn1, and Myh11 along the trajectory. Color scale, 
log gene expression. F, Gene ontology (molecular function) analysis of each gene module from (D). Full list was in Table III in the online-only Data 
Supplement. G, Expression of significantly changed genes from TGF (transforming growth factor)-β signaling pathway (KEGG) along pseudotime. 
Full list was in Table I in the online-only Data Supplement. Color scale, log gene expression. H, Tgfb2 expression and total level of significantly 
changed genes from TGF-β signaling along the pseudotime trajectory. Color scale, log gene expression. I, Expression of significantly changed 
transcription factors along the pseudotime trajectory. Full list was in Table I in the online-only Data Supplement. Color scale, log gene expression.
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Figure 4. Perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs) differentiate towards smooth muscle cells 
(SMCs) in vivo and in vitro.  
A, H&E staining of the vein graft harvested 4 wk after the transplantation. Neointimal area was calculated against injury-only control (n=4). 
Arrow indicates the boundary between neointima and media layer. B, Vein grafts harvested 1 wk after the transplantation were stained with 
RFP (red fluorescent protein; red) and SMC marker ACTA2 (smooth muscle α actin; green) (n=4). Arrows indicate cells positive for both 
markers. Dashed line indicates boundary of adventitia and neointima. Scale bar, 20 μm. C–E, In vitro cultured PV-ADSCs were differentiated 
towards SMCs in differentiation medium for 5 d (diff) and then harvested for quantitative polymerase chain reaction (qPCR; C; n=4), 
Western blot (D; n=3) and immunofluorescent staining (E; n=3) for SMC markers. Cells cultured without TGF (transforming growth 
factor)-β1 (ctrl) served as control. Scale bar, 20 μm. F, Chemotaxis of PV-ADSCs in response to an increasing gradient of SDF-1 (stromal 
cell-derived factor 1) in an 8.0-μm transwell system was identified by applying 1% crystal violet staining after 16-h incubation (n=3). 
Scale bar, 50 μm. G, H&E staining of subcutaneous Matrigel plug containing PV-ADSCs-derived SMCs and endothelial cells (ECs; diff) in 
comparison with control group (ctrl) (n=4). H, Immunostaining of the tube-like structure in Matrigel plug with ACTA2 and PECAM1 (platelet 
and endothelial cell adhesion molecule 1; n=4). Scale bar, 50 μm. Data are presented as mean±SD. *P<0.05, **P<0.01. Adv indicates 
adventitia. CNN1 indicates calponin; DAPI, 4′,6-diamidino-2-phenylindole; and TAGLN, smooth muscle protein 22-α.
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activity (Figure IXF in the online-only Data Supplement). 
However, it should be noted that cultured PV-ADSCs 
and primary Adv-Mesen cells were compared. Cell cul-
ture conditions might introduce transcriptomic differ-
ence. Collectively, cluster 2 PV-ADSCs displayed certain 
similarity with adventitial Sca1+ cells, whereas transcrip-
tomic difference was more prominent.
To explore whether PV-ADSCs participate in vascular 
remodeling in vivo, a vein graft model was used. Transplan-
tation of cultured PV-ADSCs to the adventitial side of the 
vein graft significantly promoted the neointima formation 
(Figure 4A). RFP signal in the neointimal area indicated the 
migration of the RFP-labeled PV-ADSCs from the adventi-
tial side to the neointima (Figure 4B). Numerous RFP-pos-
itive cells expressed SMC marker ACTA2 (smooth muscle 
α actin), implying that the contribution of PV-ADSCs to 
neointima formation might be partly through SMC differ-
entiation (Figure 4B). Fibroblast marker Vimentin was also 
expressed in some RFP-positive cells (Figure XA in the 
online-only Data Supplement). Notably, no colocalization of 
RFP with macrophage marker CD68 was observed, sug-
gesting that participation of PV-ADSCs in vascular remod-
eling was not through macrophage differentiation (Figure 
XB in the online-only Data Supplement).
After establishing that PV-ADSCs contribute to vas-
cular remodeling partly through SMC differentiation 
in vivo, their potential to differentiate towards SMCs 
in vitro was next explored for subsequent mechanism 
study. TGF-β1 was used as stimulus for differentiation, 
given the role of TGF-β1 signaling in SMC differentia-
tion implied by scRNA-seq. On treatment with TGF-β1, 
PV-ADSCs differentiated towards SMCs, as displayed by 
the upregulation of SMC markers including Cnn1, Tagln, 
and Acta2 at the mRNA and the protein level (Figure 4C 
through 4E). Collagen gel contraction assay demon-
strated better contractility of SMCs differentiated from 
PV-ADSCs (Figure XI in the online-only Data Supple-
ment). Since brown adipose tissue has been gradually 
recognized as a secretory organ, we also checked the 
effect of IGFBP-2 (insulin like growth factor binding pro-
tein 2), an adipokine secreted predominantly by brown 
adipose tissue,43 on PV-ADSC differentiation towards 
SMCs. High concentration (250 ng/mL) IGFBP-2 pro-
moted SMC differentiation with the presence of TGF-β1, 
whereas no effect was observed for leptin, an adipokine 
secreted mainly by white adipose tissue (Figure XIIA 
and XIIB in the online-only Data Supplement). Interest-
ingly, PV-ADSCs also expressed high level of IGFBP-2 
in comparison with ADSCs isolated from subcutaneous 
adipose tissue (Figure XIIC in the online-only Data Sup-
plement). Additionally, PV-ADSC migration towards che-
moattractant SDF-1 (stromal cell-derived factor 1) was 
also observed (Figure 4F), consistent with the notion that 
participation of PV-ADSCs in vivo involves complex pro-
cesses, including differentiation and migration.7
To further investigate the function of SMCs differenti-
ated from PV-ADSCs, the cells were mixed with mouse 
MILE SVEN 1 ECs in Matrigel and then injected subcu-
taneously in wild-type mouse to check their ability to par-
ticipate in vasculogenesis with the assistance of mature 
ECs. As exhibited by H&E staining of the subcutaneous 
Matrigel plug, a relatively large tube-like structure with 
multiple layers was formed in the plug with differentiated 
PV-ADSCs and ECs, whereas it was not found in control 
group (Figure 4G). Immunostaining of the Matrigel plug 
showed proximal localization of ACTA2 and PECAM1, 
demonstrating that the tube-like structure was a vessel 
(Figure 4H). Altogether, functional SMCs can be derived 
from PV-ADSCs.
Metabolic Reprogramming of PV-ADSCs During 
SMC Differentiation Induced by TGF-β1
Metabolic reprogramming in stem cells not only helps 
to meet the energy requirement but also drives various 
processes such as differentiation.44 To investigate meta-
bolic changes in the SMC differentiation of PV-ADSCs 
induced by TGF-β1, nuclear magnetic resonance metab-
olomics was firstly performed. Abundance of various 
detected metabolites demonstrated notable changes 
during differentiation (Figure 5A). Orthogonal projection 
to latent structures analysis depicted the distinct meta-
bolic status of differentiated PV-ADSCs (Figure 5B). 
Functionally, cells treated with TGF-β1 exhibited higher 
basal mitochondrial OCR, higher maximal mitochondrial 
OCR as well as stronger spare respiration capacity (Fig-
ure 5C). Consistently, higher mitochondrial potential was 
detected in differentiated PV-ADSCs (Figure 5D). These 
results implied that the mitochondrial oxidative metabo-
lism was enhanced during differentiation.
Further characterization of the metabolic change was 
examined with gas chromatography-mass spectrometry 
metabolomics, which is more sensitive and detects more 
metabolites. Enrichment of metabolites from tricarbox-
ylic acid cycle (Figure 5E) during differentiation indicated 
the increased mitochondrial activity, which was consis-
tent with the upregulated OCR and mitochondrial poten-
tial. Fueled by the observation that mitochondrial activity 
was increased during differentiation, we postulated that 
the reactive oxygen species might influence SMC dif-
ferentiation. However, SMC markers were not altered by 
the treatment of H2O2 (Figure XIIIA in the online-only 
Data Supplement) or the transfection of Nox4 siRNA 
(Figure XIIIB in the online-only Data Supplement) which 
changed the reactive oxygen species level. Treatment 
of carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
which potently uncoupled the electron transduction and 
oxidative phosphorylation also displayed only mild effect 
on SMC marker expression (Figure XIIIC in the online-
only Data Supplement). Notably, as indicated by the 
increased phosphoenolpyruvate and lactate level (Figure 
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XIIID in the online-only Data Supplement), glycolysis 
was also upregulated during differentiation. Functional 
characterization of glycolysis showed the upregulation of 
both the basal glycolysis and glycolysis capacity in cells 
treated with TGF-β1 (Figure XIIIE in the online-only Data 
Supplement). However, glucose uptake did not show 
much change and glucose treatment did not have effect 
on the SMC marker expression (Figure XIIIF and XIIIG in 
the online-only Data Supplement).
More extensive examination of the gas chromatogra-
phy-mass spectrometry metabolomics data revealed the 
upregulation of various lipids in differentiated PV-ADSCs 
(Figure 5F). The increased lipid together with the more 
active mitochondria suggested a potential change of lipid 
Figure 5. Metabolic reprogramming of perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs) during smooth 
muscle cells (SMC) differentiation.  
A and B, Cellular metabolite abundance was detected with nuclear magnetic resonance (NMR) system in undifferentiated PV-ADSCs and PV-
ADSCs differentiated for 1 d (n=8). A, Heatmap for metabolite levels. B, Orthogonal projection to latent structures. C, The oxygen consumption 
rate (OCR) measured in PV-ADSCs cultured with or without TGF (transforming growth factor)-β1 for 1 d (n=3). D, Live PV-ADSCs cultured in 
differentiation medium or basal growth medium for 1 and 4 d were stained tetramethylrhodamine, methyl ester, perchlorate (TMRM) to detect 
mitochondrial potential (n=3). E and F, Cellular metabolite abundance in undifferentiated PV-ADSCs or PV-ADSCs differentiated for 4 days was 
determined with gas chromatography-mass spectrometry (GC-MS) system (n=3). Heatmaps of metabolites involved in tricarboxylic acid (TCA) 
cycle (E) or lipid metabolism (F) were shown. G, Gene expression of genes important in lipid metabolism in PV-ADSCs treated with or without 
TGF-β1 for 2 d (n=4). H, Expression of Cebpb along the pseudotime trajectory. Color scale, log expression of gene. I, Crat mRNA level in PV-
ADSCs treated with or without TGF-β1 for 2 d (n=4). Data are presented as mean±SD. *P<0.05, **P<0.01, and ***P<0.001. Anti-A/Rot indicates 
anti-mycin A/Rotenone; FCCP, carbonyl cyanide-4-phenylhydrazone; MFI, mean fluorescence intensity; and SRC, spare respiratory consumption.
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metabolism. Significant changes in Ppara, Pparg, Prdm16, 
Ucp1, Cebpb, and Cebpd were observed during SMC dif-
ferentiation, supporting the hypothesis that lipid metabo-
lism drastically reprogrammed during differentiation 
(Figure 5G). Changes of these markers along the trajec-
tory and in real time further supported the reprogramming 
of lipid metabolism (Figure 5H; Figure XIV in the online-
only Data Supplement). The change of various lipid lev-
els led us to investigate the lipid oxidation process, which 
relies on the transmitochondrial transport of fatty acids 
regulated by carnitine acyltransferases including carnitine 
palmitoyltransferase 1 (Cpt1) and carnitine acetyltransfer-
ase (Crat).45 Cpt1 is responsible for the transport of long-
chain fatty acids, and Crat is responsible for the transport 
of short-chain fatty acids.45 Cpt1a and Cpt1b were not 
altered with the treatment of TGF-β1 for 2 days (Fig-
ure 5G), although Cpt1a displayed downregulation along 
trajectory (Figure XIV in the online-only Data Supplement). 
Moreover, Crat level was significantly downregulated first 
and then upregulated during SMC differentiation, which is 
supported by the early downregulation and late upregula-
tion of Crat level along SMC trajectory (Figure 5I; Figure 
XIV in the online-only Data Supplement). Thus, significant 
metabolic reprogramming was induced during SMC differ-
entiation and altered lipid metabolism implied the involve-
ment of Crat in SMC differentiation.
TGF-β1 Promotes SMC Differentiation via 
Inhibition of Crat
In SMC differentiation, TGF-β1 altered the lipid profile 
and inhibited the level of Crat. To confirm the role of Crat 
in SMC differentiation, siRNA Crat was used. Quanti-
tative polymerase chain reaction showed successful 
knockdown of Crat 2 days after Crat siRNA transfection 
(Figure 6A). SMC markers including Cnn1, Tagln, and 
Acta2 were induced at the mRNA level (Figure 6A) by 
Crat siRNA transfection. Promotion of SMC differentia-
tion by Crat knockdown was demonstrated at the protein 
level by Western blot (Figure 6B) and immunofluorescent 
staining (Figure 6C) 2 days after Crat siRNA transfec-
tion. The upregulation of TGF-β1 at the mRNA level (Fig-
ure 6D) and the protein level (Figure 6E and 6F) 2 days 
after Crat siRNA transfection identified the induction of 
TGF-β1 as the downstream mechanism of Crat-medi-
ated SMC differentiation. To conclude, an interesting 
feedback control was identified between Crat inhibition 
and TGF-β1 induction during differentiation.
MiR-378a-3p Induces Metabolic 
Reprogramming and Promotes SMC 
Differentiation
After establishing the change of the metabolic pro-
file during differentiation process and the mechanism 
involved in SMC differentiation, potential therapeutic tar-
gets that could similarly alter the metabolic profile and 
drive SMC differentiation were investigated. Literature 
mining revealed that miR-378a-3p could target Crat and 
thus regulate fatty acid metabolism which was regulated 
by TGF-β1 in our SMC differentiation system.46 To study 
the role of miR-378a-3p in metabolic reprogramming and 
SMC differentiation, PV-ADSCs were transfected with 
miR-378a-3p mimics. In Seahorse Mito Stress tests, both 
the basal OCR and maximal OCR showed an increas-
ing trend with miR-378a-3p mimic treatment compared 
with control (Figure 7A). Furthermore, the mitochondrial 
potential also increased (Figure 7B). Metabolite abun-
dance detected by gas chromatography-mass spectrom-
etry system demonstrated the enrichment of metabolites 
involved in the tricarboxylic acid cycle (Figure 7C) and 
upregulated level of various lipids, such as cholesterol 
(Figure 7D). Overall, the metabolic reprogramming 
induced by the miR-378a-3p mimics was similar to that 
induced by TGF-β1. Furthermore, miR-378a-3p mimics 
induced SMC differentiation with the significant upregu-
lation of Cnn1 and Tagln (Figure 7E). The induction of 
SMC gene expression was confirmed at the protein level 
(Figure 7F; Figure XVA in the online-only Data Supple-
ment). On the contrary, miR-378a-3p inhibitor down-
regulated mRNA level of SMC markers (Figure 7G). In 
addition, Crat expression was also derepressed in PV-
ADSCs after the transfection of miR-378a-3p inhibitors 
(Figure 7G).
Finally, TGF-β1 treatment could not induce an 
upregulation of OCR and extracellular acidification rate 
in ADSCs derived from miR-378a-3p knockout mice 
(Figure 7H), further confirming the importance of miR-
378a in inducing metabolic reprogramming. Also, SMC 
differentiation capacity was significantly attenuated in 
ADSCs derived from miR-378a knockout mice as shown 
by the lower level of CNN1 (calponin) compared with 
ADSCs from wild-type mice after the treatment with 
TGF-β1 (Figure 7I; Figure XVB in the online-only Data 
Supplement). Interestingly, level of miR-378a-3p was 
downregulated by TGF-β1 treatment (Figure XVC in the 
online-only Data Supplement). In summary, metabolic 
reprogramming and SMC differentiation were induced by 
miR-378a-3p, which was an indispensable component 
for TGF-β1 to exert the metabolic regulation.
DISCUSSION
In this study, we characterized the transcriptomic profile 
of PV-ADSCs at a single-cell level and determined their 
role in vascular remodeling through their differentiation 
towards smooth muscle lineage which was accompa-
nied by metabolic reprogramming. Substantial hetero-
geneity was observed at the single-cell level in primary 
PV-ADSCs. Moreover, through differentiation towards 
smooth muscle lineage, cultured PV-ADSCs were 
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suggested to contribute to vascular remodeling in vein 
graft models. Mechanistically, SMC differentiation from 
PV-ADSCs was accompanied by a metabolic reprogram-
ming which could be induced by miR-378a-3p.
To characterize the PV-ADSCs, scRNA-seq was 
performed and revealed 2 distinct clusters within the 
CD45−/CDH5−/CD29+/Sca1+ population, as well as the 
signature gene sets and feature signaling pathways for 
each cluster. However, attention needs to be paid to the 
markers used to identify the MSCs. About 60.15±3.77% 
of the CD45−/CDH5− population were CD29+/Sca1+. 
Thus, the scRNA-seq result only covers this population 
and remaining cells necessitate further characteriza-
tion. Furthermore, multiple cluster 1 markers including 
Pecam1 and Cd36 displayed low percentage expression 
in in vitro cultured PV-ADSCs, which suggested difficult 
retainment of these markers in present culture condition 
or selective expansion of cluster 2 cells. Future efforts 
including selective culture of cells from each cluster and 
separate determination of their contribution to vascular 
remodeling are needed.
Consistent with what has been reported for MSCs,47,48 
considerable heterogeneity of PV-ADSCs has been 
observed in our study, which serves as direct evidence 
for stem cells from the perivascular (periaorta) adipose 
tissue. Although transcriptional network heterogeneity of 
stromal vascular fraction from axillary adipose tissue was 
reported,49 PVAT is more relevant to vascular function.1 
With scRNA-seq, heterogeneous intracellular markers 
and functional modules have also been described in our 
study. Because of this substantial heterogeneity, markers 
that are used to identify MSC population by itself, such 
as Tbx1837, might only label a subpopulation. To over-
come the laborious efforts to generate lineage tracing 
models for all the heterogeneously expressed markers 
used for MSC identification, more specific markers need 
to be discovered. In our study, Tgfbr2 and Anxa1 char-
acterize cluster 2 PV-ADSCs specifically and bears the 
Figure 6. Crat knockdown promotes smooth muscle cells (SMC) differentiation via upregulation of TGF (transforming 
growth factor)-β1.  
A–C, Perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs) treated with Crat siRNA with or without TGF-β1 for 2 d. A, Crat 
level was significantly downregulated after siRNA Crat transfection. Quantitative polymerase chain reaction (qPCR) also showed the induction 
of SMC markers (Cnn1, Tagln, and Acta2) with Crat knockdown. B, Protein level induction of SMC markers by Crat siRNA was demonstrated 
by Western blot. C, Immunostaining and statistical analysis showed the induction of SMC markers by Crat siRNA in medium without TGF-β1. 
D–F, TGF-β1 level after Crat siRNA transfection for 2 d was determined with qPCR (D), Western blot (E), and immunofluorescent staining 
(F). Results are cumulative (A and D) or representative (B, C, E, and F) of 3 independent experiments. Scale bar, 30 μm. Data are presented 
as mean±SD. *P<0.05, **P<0.01, and ***P<0.001. ACTA2 indicates smooth muscle α actin; CNN1, calponin; DAPI, 4′,6-diamidino-2-
phenylindole; and TAGLN, smooth muscle protein 22-α.
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Figure 7. MicroRNA (miR)-378a-3p induces metabolic reprogramming and promotes smooth muscle cells (SMC) differentiation.  
A, The oxygen consumption rate (OCR) of perivascular adipose tissue-derived mesenchymal stem cells (PV-ADSCs) cultured in miR-
378a-3p mimics or control for 2 d (n=3). B, Live PV-ADSCs treated with miR-378a-3p mimic for 2 d with or without TGF (transforming 
growth factor)-β1 were stained tetramethylrhodamine, methyl ester, perchlorate (TMRM) and analyzed for mean fluorescence intensity (MFI) 
with flow cytometry (n=3). C and D, Cellular metabolite abundance in PV-ADSCs treated with miR-378a-3p mimics for 1 d determined 
with gas chromatography-mass spectrometry (GC-MS) system (n=3). Heatmap of metabolites in tricarboxylic acid (TCA) cycle (C) or lipid 
metabolism (D). E, SMC marker mRNAs were induced by miR-378a-3p mimics after 2 d (n=3). F, Representative immunofluorescent 
staining (n=3) showed the upregulation of SMC markers by miR-378a-3p mimic treatment. G, Transfection of PV-ADSCs with miR-
378a-3p inhibitor inhibited the level of SMC markers as shown by quantitative polymerase chain reaction (qPCR). The level of Crat 
was derepressed by miR-378a-3p inhibitor transfection (n=3). H, OCR and extracellular acidification rate (ECAR) were detected with 
Seahorse Mito stress tests in wild-type (WT) and miR-378a knockout (KO) ADSCs (n=3). I, WT and miR-378a KO ADSCs were treated 
with or without TGF-β1 for 2 d. Immunofluorescent staining showed the protein level of CNN1 (calponin; n=1). Scale bar, 100 μm. Data are 
mean±SD. *P<0.05 and **P<0.01. Anti-A/Rot indicates anti-mycin A/Rotenone; Crat, carnitine acetyltransferase; FCCP, carbonyl cyanide-
4-phenylhydrazone; inh 378, miR-378a-3p inhibitor; inh ctrl, inhibitor control; mim 378, miR-378a-3p mimics; mim ctrl, mimics control; and 
SRC, spare respiratory capacity.
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potential to identify this population homogenously in vivo. 
However, because of the limited number of primary PV-
ADSCs, only a small number of cells were sequenced in 
our study. This is one limitation of the study. Sequencing 
of more primary cells would provide the possibility to dis-
cover better identity markers unique for MSC population 
or subpopulation. Another limitation of the study mainly 
lies in the lack of in vivo evidence for PV-ADSC contri-
bution to vascular injury repair. Future investigations of 
in vivo PV-ADSC fate labeled by markers found by this 
study and future scRNA-seq data with larger cell number 
are needed.
Under disease settings such as atherosclerosis and 
vascular injury, adventitial stem cells migrate to the 
injury site and differentiate towards vascular lineages 
in response to the cytokine profile changes.50,51 Similar 
explorations of PV-ADSC responses in diseased status 
would provide novel therapeutic insights. Cell transplan-
tation experiments of RFP-labeled PV-ADSCs in vein 
graft transplantation experiments confirmed their involve-
ment in vascular remodeling, similar to adventitial stem 
cells. Preliminary result demonstrating the migration of 
PV-ADSCs towards chemoattractant SDF-1 suggests 
that cell migration is among the complex mechanisms 
through which PV-ADSCs participate in vascular injury 
repair and thus is a potentially interesting field. These 
findings together expand the pool of the resident vascu-
lar stem cell population consisting adventitial stem cells 
to include MSCs that reside in the PVAT. Lineage trac-
ing studies with markers identified by scRNA-seq are 
in need to further assess the in vivo physiological and 
pathophysiological role of PV-ADSCs.
Regarding the differentiation mechanism, accumulat-
ing evidence has demonstrated the importance of met-
abolic reprogramming in stem cell differentiation.11,44 It 
was shown that increased glycolysis is associated with 
pluripotency and increased mitochondrial respiration is 
associated with differentiation in pluripotent stem cells.52 
MSCs displayed suppressed glycolysis when driven to 
differentiation towards osteocytes.53 Our study charac-
terized the metabolic profile change of PV-ADSCs dur-
ing SMC differentiation and proposed the importance of 
lipid metabolism in regulating the differentiation process. 
MiR-378-3a bears potential in regulating SMC differen-
tiation. Efforts are needed to further validate the function 
of miR-378-3a in vascular injury models and explore its 
therapeutic potential.
Evidence of the important role of the adipose-vascular 
crosstalk in various metabolic diseases has identified 
novel targets such as perivascular relaxing factors54 or 
secreted adipokines55 with significant therapeutic poten-
tial. By demonstrating the role of PV-ADSCs in vascu-
lar remodeling through metabolism-related regulation of 
SMC differentiation, our results support the need to further 
investigate the role of PV-ADSCs in vascular remodeling 
in various metabolic diseases such as atherosclerosis and 
diabetes mellitus. The process of PV-ADSC-involved vas-
cular remodeling, which was not recognized before, might 
be targeted in future therapeutic development for meta-
bolic diseases. Potential future exploration also includes 
the influence of adipokines secreted by PVAT on PV-
ADSC differentiation and function, especially under dis-
ease conditions, given that preliminary results have shown 
the promoting effect of IGFBP-2 on SMC differentiation. 
Collectively, our study provides direct evidence of PV-
ADSC heterogeneity through high-resolution character-
ization with scRNA-seq and suggests their participation 
in vascular remodeling through SMC differentiation driven 
by metabolic reprogramming which necessitate confirma-
tion with further in vivo lineage tracing experiments. Taken 
together, the results imply the previously unappreciated 
identity and function of PV-ADSCs in vascular remodel-
ing, unveil the mechanism for SMC differentiation from 
a metabolic perspective and provide insights for future 
studies to investigate the role of PV-ADSCs in various 
metabolic diseases.
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